Author:
Fujita Hirofumi,Kurokawa Kazuko,Ogino Tetsuya,Ono Mio,Yamamoto Masanao,Oka Takashi,Nakanishi Tohru,Kobayashi Naoya,Tanaka Noriaki,Ogawa Tomohiro,Suzaki Etsuko,Utsumi Kozo,Sasaki Junzo
Subject
Pharmacology,Toxicology,General Medicine
Reference49 articles.
1. Mechanisms of action of bisphosphonates;Rodan;Annu Rev Pharmacol Toxicol,1998
2. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent posttranslational prenylation of GTP-binding proteins, including Ras;Luckman;J Bone Miner Res,1998
3. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro;Fisher;Proc Natl Acad Sci USA,1999
4. Bisphosphonates act directly on the osteoclast to induce caspase cleavage of Mst1 kinase during apoptosis;Reszka;J Biol Chem,1999
5. The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralization of human bone-derived cells in vitro;Pan;Bone,2004
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献